• Source: MDMB-BINACA

MDMB-BINACA (MDMB-BUTINACA) is an indazole-3-carboxamide based synthetic cannabinoid receptor agonist that has been sold as a designer drug, first identified in Sweden in May 2023. It has a similar chemical structure to potent cannabinoid agonists previously reported such as ADB-BUTINACA and MDMB-5'Br-BUTINACA, and is believed to have similar effects.




See also


4F-MDMB-BINACA
ADB-5'F-BUTINACA
ADB-5'Br-BUTINACA
JWH-073




References

Kata Kunci Pencarian:

• 4F-MDMB-BINACA
• MDMB-BINACA
• MDMB-4en-PINACA
• ADB-BINACA
• 5F-MDMB-PICA
• MDMB-FUBINACA
• ADB-BUTINACA
• 5F-ADB
• MDMB-CHMICA
• MDMB-CHMINACA